Canada markets open in 3 hours 27 minutes

Jiangsu Hengrui Medicine Co., Ltd. (600276.SS)

Shanghai - Shanghai Delayed Price. Currency in CNY
Add to watchlist
46.16-0.02 (-0.04%)
At close: 03:00PM CST
Currency in CNY

Valuation Measures4

Market Cap (intraday) 294.45B
Enterprise Value 272.76B
Trailing P/E 65.94
Forward P/E 59.52
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)12.52
Price/Book (mrq)7.03
Enterprise Value/Revenue 11.69
Enterprise Value/EBITDA 56.38

Trading Information

Stock Price History

Beta (5Y Monthly) 0.22
52-Week Change 3-6.31%
S&P500 52-Week Change 323.57%
52 Week High 350.50
52 Week Low 335.51
50-Day Moving Average 344.48
200-Day Moving Average 343.86

Share Statistics

Avg Vol (3 month) 329.82M
Avg Vol (10 day) 333.18M
Shares Outstanding 56.38B
Implied Shares Outstanding 66.69B
Float 83.5B
% Held by Insiders 148.59%
% Held by Institutions 116.08%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 40.16
Forward Annual Dividend Yield 40.35%
Trailing Annual Dividend Rate 30.20
Trailing Annual Dividend Yield 30.43%
5 Year Average Dividend Yield 40.31
Payout Ratio 422.86%
Dividend Date 3N/A
Ex-Dividend Date 4Jun 08, 2023
Last Split Factor 21.2:1
Last Split Date 3Jun 10, 2021

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 19.00%
Operating Margin (ttm)24.64%

Management Effectiveness

Return on Assets (ttm)6.22%
Return on Equity (ttm)10.77%

Income Statement

Revenue (ttm)23.32B
Revenue Per Share (ttm)3.69
Quarterly Revenue Growth (yoy)9.20%
Gross Profit (ttm)N/A
EBITDA 5.09B
Net Income Avi to Common (ttm)4.43B
Diluted EPS (ttm)0.70
Quarterly Earnings Growth (yoy)10.50%

Balance Sheet

Total Cash (mrq)21.77B
Total Cash Per Share (mrq)3.34
Total Debt (mrq)78.4M
Total Debt/Equity (mrq)0.19%
Current Ratio (mrq)9.12
Book Value Per Share (mrq)6.42

Cash Flow Statement

Operating Cash Flow (ttm)8.68B
Levered Free Cash Flow (ttm)5.93B